The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Cohen Ron since year 2005.
The trader's CIK number is 1272354.
At the time of this reporting, Cohen Ron is the President and CEO of Acorda Therapeutics Inc .
(stock ticker symbol ACOR).
See this page for all insider trading activities at Acorda Therapeutics Inc .
Stock purchases, sales, and option exercises reported by insider Cohen Ron since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-07-08
ACOR
Acorda Therapeutics Inc
Sale
11,900
31.39
373,587
2008-07-08
ACOR
Acorda Therapeutics Inc
Option Exercise
25,000
2.60
65,000
2008-07-08
ACOR
Acorda Therapeutics Inc
Sale
13,100
31.15
408,089
2008-06-05
ACOR
Acorda Therapeutics Inc
Sale
9,800
32.14
314,923
2008-06-05
ACOR
Acorda Therapeutics Inc
Sale
40,200
31.64
1,271,741
2008-06-05
ACOR
Acorda Therapeutics Inc
Option Exercise
50,000
2.60
130,000
2008-03-10
ACOR
Acorda Therapeutics Inc
Sale
5,500
18.11
99,614
2008-03-10
ACOR
Acorda Therapeutics Inc
Sale
2,600
17.58
45,714
2007-12-10
ACOR
Acorda Therapeutics Inc
Sale
8,000
20.43
163,448
2007-09-10
ACOR
Acorda Therapeutics Inc
Sale
8,000
16.16
129,273
2007-08-13
ACOR
Acorda Therapeutics Inc
Sale
22,473
17.15
385,466
2007-08-13
ACOR
Acorda Therapeutics Inc
Sale
3,527
16.32
57,578
2007-08-14
ACOR
Acorda Therapeutics Inc
Sale
26,000
16.95
440,575
2007-08-09
ACOR
Acorda Therapeutics Inc
Sale
26,000
17.78
462,149
2007-08-10
ACOR
Acorda Therapeutics Inc
Sale
26,000
17.00
441,979
2006-12-01
ACOR
Acorda Therapeutics Inc
Sale
7,591
18.96
143,940
2006-11-01
ACOR
Acorda Therapeutics Inc
Sale
35,980
17.25
620,798
2006-11-01
ACOR
Acorda Therapeutics Inc
Sale
14,020
16.85
236,295
2006-10-16
ACOR
Acorda Therapeutics Inc
Sale
22,000
16.20
356,338
2006-10-16
ACOR
Acorda Therapeutics Inc
Sale
28,000
16.59
464,501
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cohen Ron
(President and CEO of Acorda Therapeutics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
